Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998US5792453 Transfecting cells in coronary arteries by injection of a transgene-inserted replication-deficit adenovirus; antiischemic agents; cardiotonic agents; vascular disease
08/11/1998US5792451 Oral drug delivery compositions and methods
08/11/1998US5792450 Purified human CSF-1
08/11/1998US5792444 Labeled chemotactic peptides to image focal sites of infection or inflammation
08/11/1998CA2083162C Enzymatic neutralization of heparin
08/11/1998CA2029599C Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
08/11/1998CA1339997C Peptides for circulatory system control
08/11/1998CA1339992C Anticoagulant polypeptede
08/11/1998CA1339990C Compositions and method for the treatment or prophylaxis of sepsis or septic shock
08/10/1998CA2223008A1 Def1
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998033942A1 Diagnosis and treatment of myocardial failure
08/06/1998WO1998033937A2 GENOMIC SEQUENCE OF THE HUMAN ν-OPIOID RECEPTOR GENE AND THE VARIANTS, POLYMORPHISMS AND MUTATIONS THEREOF
08/06/1998WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033917A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998WO1998033913A1 Human integral membrane protein
08/06/1998WO1998033912A1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE
08/06/1998WO1998033911A1 Human signal transduction protein regulating the nuclear movement
08/06/1998WO1998033910A1 Novel proline-rich membrane protein
08/06/1998WO1998033909A1 Novel human atpase inhibitor protein
08/06/1998WO1998033908A1 Human c5a-like receptor
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033905A1 K-atp channels, materials and methods relating to cell membrane proteins
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033893A2 Ribozymes cleaving epidermal growth factor receptors
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033889A1 Adipocyte culture
08/06/1998WO1998033888A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998WO1998033887A1 Growth differentiation factor-8
08/06/1998WO1998033883A1 Regulators of apoptosis
08/06/1998WO1998033819A1 Cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
08/06/1998WO1998033818A1 Human anion channel
08/06/1998WO1998033817A1 Human membrane protein
08/06/1998WO1998033816A1 Nucleic acid encoding an acetyl-coenzyme-a transporter protein
08/06/1998WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof)
08/06/1998WO1998033814A1 THE 74 KILODALTON OUTER MEMBRANE PROTEIN FROM $i(MORAXELLA CATARRHALIS)
08/06/1998WO1998033813A2 Method for accelerating healing of thermal injuries
08/06/1998WO1998033812A1 Mast cell protease peptide inhibitors
08/06/1998WO1998033811A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998WO1998033807A1 Anti-viral guanosine-rich tetrad forming oligonucleotides
08/06/1998WO1998033535A1 System, method and composition for dialysis and shock treatment
08/06/1998WO1998033533A1 A stabilized mixture comprising fibrinogen
08/06/1998WO1998033529A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033524A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
08/06/1998WO1998033519A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
08/06/1998WO1998033518A1 Mutants of thymidylate synthase and uses thereof
08/06/1998WO1998033517A1 Use of interferon alpha subtypes for enhancing immune response
08/06/1998WO1998033516A1 Use of il-4 and/or il-10 to treat proliferative glomerulonephritis
08/06/1998WO1998033515A1 STIMULATORY EFFECTS OF bFGF AND BMP-2 ON OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
08/06/1998WO1998033514A1 Freeze-dried composition of bone morphogenetic protein human mp52
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033512A1 Oil-free pharmaceutical compositions containing cyclosporin a
08/06/1998WO1998033511A1 Structurally modified peptides resistant to peptidase degradation
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033491A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
08/06/1998WO1998033480A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
08/06/1998WO1998033475A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998WO1998027113A3 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
08/06/1998WO1998024813A3 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
08/06/1998WO1998023959A3 Diagnosis and treatment of insulin-dependent diabetes mellitus
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998020034A3 Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998WO1998002148A3 Pharmaceutical composition
08/06/1998WO1998001462A3 Urogenital carcinoma TLP complex peptides and antibodies thereof
08/06/1998DE19703699A1 Combination preparation for immunological diagnosis and treatment
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279577A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998CA2279548A1 Ribozymes cleaving epidermal growth factor receptors
08/06/1998CA2279547A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279488A1 Anti-viral guanosine-rich tetrad forming oligonucleotides
08/06/1998CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998CA2279419A1 A stabilized mixture comprising fibrinogen
08/06/1998CA2279348A1 System, method and composition for dialysis and shock treatment
08/06/1998CA2279345A1 Tissue factor pathway inhibitor-3
08/06/1998CA2279344A1 Human c5a-like receptor
08/06/1998CA2279265A1 Novel human cystatin-like protein
08/06/1998CA2278849A1 A tumor suppressor designated ts10q23.3
08/06/1998CA2278848A1 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998CA2278847A1 Method for the production of selected lymphocytes
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
1 ... 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 ... 3163